Exhibit 99.1
| | | | |
| | | | Food and Drug Administration 466 Fernandez Juncos Avenue San Juan, Puerto Rico, 00901 Telephone: 787-729-8500 FAX: 787-729-8826 |
January 14, 2015
15-SJN-WLCOL-03
CERTIFIED MAIL
RETURN RECEIPT REQUESTED
Mr. Peter Arduini
President and CEO
Integra Life-Sciences Corporation
311 Enterprise Drive,
Plainsboro, N.J. 08536
Dear Mr. Arduini:
We have completed an evaluation of your firm’s corrective actions in response to our Warning Letter 13-SJN-WL-03 dated February 13, 2013. Based on our evaluation, it appears that you have addressed the violations contained in this Warning Letter.
This letter does not relieve you or your firm from the responsibility of taking all necessary steps to assure sustained compliance with the Federal Food, Drug, and Cosmetic Act and its implementing regulations or with other relevant legal authority. The Agency expects you and your firm to maintain compliance and will continue to monitor your state of compliance. This letter will not preclude any future regulatory action should violations be observed during a subsequent inspection or through other means.
Should you have questions and/or comments regarding this matter, please feel free to contact me at the district office address provided in the letterhead. You may also contact Mrs. Margarita Santiago, Compliance Officer at telephone number (787) 729-8702 or atmargarita.santiago@fda.hhs.gov.
|
Kind regards, |
|
 |
| Edwin Ramos |
| Director of Compliance |
| San Juan District Office |
Mr. Peter Arduini, President and CEO, Integra Neurosciences P.R., Inc., 15-SJN-WLCOL-03
Page 2
| | | | | | | | |
Reviewed by: | |  | | | | Date: | | 1/14/15 |
| | | | | | | | |
CB: WL Legal File
FEI: 3000204775
CMS Case: 392719
